Tongfang Kontafarma Holdings Limited
HKEX:1312.HK
0.032 (HKD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 809.107 | 894.062 | 961.089 | 1,009.134 | 1,482.347 | 2,093.724 | 1,344.336 | 633.279 | 465.739 | 733.125 | 703.468 | 704.698 | 725.298 | 451.444 |
| Cost of Revenue
| 337.815 | 387.841 | 478.2 | 453.385 | 733.64 | 1,530.726 | 1,007.461 | 539.16 | 441.537 | 663.039 | 632.912 | 645.867 | 613.453 | 399.596 |
| Gross Profit
| 471.292 | 506.221 | 482.889 | 555.749 | 748.707 | 562.998 | 336.875 | 94.119 | 24.202 | 70.086 | 70.556 | 58.831 | 111.845 | 51.848 |
| Gross Profit Ratio
| 0.582 | 0.566 | 0.502 | 0.551 | 0.505 | 0.269 | 0.251 | 0.149 | 0.052 | 0.096 | 0.1 | 0.083 | 0.154 | 0.115 |
| Reseach & Development Expenses
| 20.75 | 29.11 | 45.633 | 35.705 | 33.706 | 25.283 | 23.727 | 4.47 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 113.023 | 115.331 | 132.686 | 139.667 | 157.998 | 156.275 | 138.808 | 100.491 | 60.842 | 47.152 | 42.164 | 38.561 | 35.577 | 17.753 |
| Selling & Marketing Expenses
| 429.469 | 443.355 | 356.54 | 367.045 | 342.951 | 243.605 | 133.027 | 34.9 | 5.655 | 6.423 | 4.584 | 3.856 | 4.183 | 4.529 |
| SG&A
| 542.492 | 558.686 | 489.226 | 506.712 | 500.949 | 399.88 | 271.835 | 135.391 | 66.497 | 53.575 | 46.748 | 42.417 | 39.76 | 22.282 |
| Other Expenses
| 0 | -12.083 | -31.879 | -43.859 | -19.23 | 34.147 | 6.802 | -6.837 | -10.49 | -21.844 | -8.716 | -32.979 | 5.131 | -69.187 |
| Operating Expenses
| 471.292 | 546.603 | 502.98 | 462.853 | 481.719 | 379.68 | 280.96 | 120.814 | 56.007 | 31.731 | 38.032 | 9.438 | -1.78 | -537.712 |
| Operating Income
| -63.247 | -47.063 | -42.556 | 40.388 | 305.805 | 200.306 | 59.986 | -7.964 | -11.323 | 57.857 | 53.46 | 74.741 | 122.699 | 520.373 |
| Operating Income Ratio
| -0.078 | -0.053 | -0.044 | 0.04 | 0.206 | 0.096 | 0.045 | -0.013 | -0.024 | 0.079 | 0.076 | 0.106 | 0.169 | 1.153 |
| Total Other Income Expenses Net
| 19.328 | -33.329 | -11.909 | -40.685 | -174.115 | -74.452 | -24.016 | 18.145 | 13.613 | -11.75 | 30.094 | -28.225 | -4.889 | -74.069 |
| Income Before Tax
| -43.919 | -117.736 | -0.326 | -0.297 | 121.671 | 108.866 | 35.97 | -20.128 | -26.985 | 46.107 | 62.618 | 46.516 | 117.81 | 515.491 |
| Income Before Tax Ratio
| -0.054 | -0.132 | -0 | -0 | 0.082 | 0.052 | 0.027 | -0.032 | -0.058 | 0.063 | 0.089 | 0.066 | 0.162 | 1.142 |
| Income Tax Expense
| 17.196 | -7.992 | 4.227 | 19.788 | 56.46 | 37.354 | 0.119 | 7.425 | 2.829 | 18.083 | 16.396 | 9.384 | 29.321 | 140.976 |
| Net Income
| -28.843 | -109.744 | -4.553 | -20.085 | 65.211 | 32.499 | -1.806 | -37.076 | -34.237 | 17.28 | 32.564 | 26.834 | 76.158 | 168.332 |
| Net Income Ratio
| -0.036 | -0.123 | -0.005 | -0.02 | 0.044 | 0.016 | -0.001 | -0.059 | -0.074 | 0.024 | 0.046 | 0.038 | 0.105 | 0.373 |
| EPS
| -0.005 | -0.02 | -0.001 | -0.004 | 0.012 | 0.006 | -0 | -0.008 | -0.007 | 0.004 | 0.008 | 0.008 | 0.043 | 0.096 |
| EPS Diluted
| -0.005 | -0.02 | -0.001 | -0.004 | 0.012 | 0.006 | -0 | -0.008 | -0.007 | 0.004 | 0.008 | 0.008 | 0.043 | 0.096 |
| EBITDA
| 76.633 | 26.929 | 112.178 | 156.306 | 419.172 | 259.813 | 134.87 | 30.714 | 14.902 | 82.89 | 89.668 | 71.382 | 142.153 | 534.456 |
| EBITDA Ratio
| 0.095 | 0.094 | 0.107 | 0.184 | 0.314 | 0.135 | 0.087 | 0.033 | 0.025 | 0.109 | 0.107 | 0.135 | 0.196 | 1.18 |